Tallimustine

Catalog No. :
ACRGKF836
CAS No. :
115308-98-0
Molecular Formula :
C32H38Cl2N10O4
Molecular Weight :
697.63

IUPAC Name:N-(3-amino-3-iminopropyl)-4-(4-(4-(4-(bis(2-chloroethyl)amino)benzamido)-1-methyl-1H-pyrrole-2-carboxamido)-1-methyl-1H-pyrrole-2-carboxamido)-1-methyl-1H-pyrrole-2-carboxamide

Tallimustine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTallimustine
IUPAC NameN-(3-amino-3-iminopropyl)-4-(4-(4-(4-(bis(2-chloroethyl)amino)benzamido)-1-methyl-1H-pyrrole-2-carboxamido)-1-methyl-1H-pyrrole-2-carboxamido)-1-methyl-1H-pyrrole-2-carboxamide
Molecular FormulaC32H38Cl2N10O4
Molecular Weight697.63
SMILESO=C(C1=CC(NC(C2=CC(NC(C3=CC(NC(C4=CC=C(N(CCCl)CCCl)C=C4)=O)=CN3C)=O)=CN2C)=O)=CN1C)NCCC(N)=N
InChI KeyARKYUICTMUZVEW-UHFFFAOYSA-N
SynonymTallimustine;FCE-24517;N-[5-[[(3-Amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-[4-[bis(2-chloroethyl)amino]benzoylamino]-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide;Talimustine;1H-Pyrrole-2-carboxamide, N-[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-[[4-[bis(2-chloroethyl)amino]benzoyl]amino]-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-;Tallimustine USP/EP/BP
CAS No.115308-98-0

Synthetic Route by SureRoute

1. ACRGKF836 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRGKF836 route product structure diagram
    ACRGKF836115308-98-0
Inquiry

2. ACRGKF836 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRGKF836 route product structure diagram
    ACRGKF836115308-98-0
Inquiry

Comments (0)